PT-141

PT-141 is a synthetic melanocortin receptor agonist derived from α-MSH, studied in advanced research models for its effects on central nervous system signaling, motivation pathways, and neuroendocrine communication. Unlike compounds that act peripherally, PT-141 operates primarily within the central nervous system, allowing researchers to investigate brain-mediated behavioral responses.

Its mechanism involves activation of melanocortin receptors within the brain, particularly those associated with motivation, arousal, and neurological signaling. This central action makes it highly relevant in studies focused on neurobehavioral pathways, hormonal signaling integration, and the interaction between brain chemistry and physiological response.

Manufactured in the United States and verified at ≥99% purity through HPLC and mass spectrometry analysis, each multidose vial meets strict research grade standards for identity, purity, and consistency.

In controlled research environments, PT-141 has been studied for its role in melanocortin receptor activation, neuroendocrine signaling, behavioral response pathways, and models involving central nervous system-mediated physiological processes.

Key Research Focus Areas:

• Melanocortin receptor activation (central pathways)
• Neuroendocrine signaling and communication
• Behavioral and motivation pathway research
• Central nervous system response models
• Brain-mediated physiological signaling

Quality & Compliance:

• ≥99% purity (HPLC & Mass Spectrometry verified)
• Manufactured in the USA
• Third-party tested by independent U.S. laboratories
• Sterile, lyophilized, multidose vial

Important Notice:

For research purposes only. Not for human consumption. Not intended to diagnose, treat, cure, or prevent any disease.